These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18407110)

  • 1. Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease.
    Seibel MJ; Robins SP; Bilezikian JP
    Trends Endocrinol Metab; 1992 Sep; 3(7):263-70. PubMed ID: 18407110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases.
    Robins SP; Black D; Paterson CR; Reid DM; Duncan A; Seibel MJ
    Eur J Clin Invest; 1991 Jun; 21(3):310-5. PubMed ID: 1909635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.
    Seibel MJ; Woitge H; Scheidt-Nave C; Leidig-Bruckner G; Duncan A; Nicol P; Ziegler R; Robins SP
    J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxypyridinium collagen crosslinks in serum, urine, synovial fluid and synovial tissue in patients with rheumatoid arthritis compared with osteoarthritis.
    Kaufmann J; Mueller A; Voigt A; Carl HD; Gursche A; Zacher J; Stein G; Hein G
    Rheumatology (Oxford); 2003 Feb; 42(2):314-20. PubMed ID: 12595629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of pyridinium crosslinks and N-terminal crosslinked peptide in preterm and term infants.
    Gfatter R; Braun F; Herkner K; Kohlross C; Hackl P
    Int J Clin Lab Res; 1997; 27(4):238-43. PubMed ID: 9506267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
    Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
    J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone resorption markers].
    Takahashi M; Inoue T
    Rinsho Byori; 1996 May; 44(5):415-22. PubMed ID: 8676559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P; Gineyts E; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture.
    McLaren AM; Hordon LD; Bird HA; Robins SP
    Ann Rheum Dis; 1992 May; 51(5):648-51. PubMed ID: 1616331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in biochemical markers for osteoporosis.
    Garnero P; Delmas PD
    Calcif Tissue Int; 1996; 59 Suppl 1():S2-9. PubMed ID: 8974724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease.
    Coleman RE; Houston S; James I; Rodger A; Rubens RD; Leonard RC; Ford J
    Br J Cancer; 1992 May; 65(5):766-8. PubMed ID: 1586605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urinary excretion of the collagen degradation markers pyridinoline and deoxypyridinoline in an experimental rat model of alcoholic bone disease.
    Preedy VR; Sherwood RA; Akpoguma CI; Black D
    Alcohol Alcohol; 1991; 26(2):191-8. PubMed ID: 1878079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody assay for free urinary pyridinium cross-links.
    Gomez B; Ardakani S; Evans BJ; Merrell LD; Jenkins DK; Kung VT
    Clin Chem; 1996 Aug; 42(8 Pt 1):1168-75. PubMed ID: 8697572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers of bone metabolism.
    Tohmé JF; Seibel MJ; Silverberg SJ; Robins SP; Bilezikian JP
    Z Rheumatol; 1991; 50(3):133-41. PubMed ID: 1927060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of pyridinium crosslinks, pyridinoline and deoxypyridinoline, for use as biochemical markers of collagen degradation.
    Robins SP; Duncan A; Wilson N; Evans BJ
    Clin Chem; 1996 Oct; 42(10):1621-6. PubMed ID: 8855145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of pyridinium crosslinks in healthy 4-10 year olds.
    Husain SM; Mughal Z; Williams G; Ward K; Smith CS; Dutton J; Fraser WD
    Arch Dis Child; 1999 Apr; 80(4):370-3. PubMed ID: 10086947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
    Seibel MJ; Cosman F; Shen V; Gordon S; Dempster DW; Ratcliffe A; Lindsay R
    J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers for assessing skeletal growth.
    Robins SP
    Eur J Clin Nutr; 1994 Feb; 48 Suppl 1():S199-209. PubMed ID: 8005087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen cross-link metabolites in urine as markers of bone metastases in prostatic carcinoma.
    Miyamoto KK; McSherry SA; Robins SP; Besterman JM; Mohler JL
    J Urol; 1994 Apr; 151(4):909-13. PubMed ID: 7510346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of biochemical markers of bone resorption in patients with metabolic and malignant bone diseases.
    Withold W; Friedrich W; Reinauer H
    Ann Clin Biochem; 1996 Sep; 33 ( Pt 5)():421-7. PubMed ID: 8888974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.